{"title":"Implementation challenges of government-funded health schemes for cancer treatment at Tata Memorial Centre","authors":"Suvarna Gore , Sharyu Mhamane , Sunita Jadhav , Narpat Padvi , Amruta Mhatre , Prachi Joshi , Sandeep Sawakare , Vinit Samant , Pankaj Chaturvedi , C.S. Pramesh , Sudeep Gupta , Atul Budukh","doi":"10.1016/j.jcpo.2025.100564","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The study aims to understand the Ayushman Bharat- Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) and Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY)health scheme awareness, challenges faced by the scheme beneficiaries, facilitators and out-of-pocket expenditure (OOPE) for cancer treatment at Tata Memorial Hospital, Mumbai.</div></div><div><h3>Methods</h3><div>We conducted an observational cross-sectional study approved by the Tata Memorial Centre Ethics Committee. We collected data by interviewing participants through a structured questionnaire.</div></div><div><h3>Results</h3><div>Out of 515 participants, 489 (95 %) were beneficiaries (patients/caregivers) of the schemes, 15 (2.9 %) MJPJAY staff, 6 (1.1 %) medical social workers (MSW), and 5 (1.0 %) AB PM-JAY staff. Of the 489 beneficiaries, only 162 (33.1 %) were aware of the scheme. Most patients were satisfied with the benefits of the scheme; of the 83 (17 %) who were dissatisfied, 30 (36 %) cited incomplete coverage at a 95 % Confidence Interval (CI) [0.26–0.46] and 19 (23 %) 95 % CI [0.14–0.32] cited OOPE as the reason for dissatisfaction. Participants opined a need to increase package coverage of cancer treatment and essential investigations. The beneficiaries highlighted delays in the approval process and technical issues of the scheme as potential areas of improvement.</div></div><div><h3>Conclusion</h3><div>Government health schemes are effective in improving treatment completion without impoverishment and have the potential to improve treatment outcomes and cancer survival. Study results indicate the need to increase awareness about these schemes in the general population, improving the health benefit packages for cancer treatment, with inclusion investigations, supportive care, nutritional care, palliative care, immunotherapy, chemotherapy drugs, targeted therapy, bone marrow transplantation, and hormonal therapy.</div></div><div><h3>Policy summary</h3><div>Government-funded health schemes are effective in reducing impoverishment related to healthcare costs and promoting Universal Health Coverage. However, periodic review of the breadth of coverage as well as feasibility of completing treatment using these packages is necessary to eliminate out-of-pocket expenditure and facilitate treatment completion.</div></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"43 ","pages":"Article 100564"},"PeriodicalIF":2.0000,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Policy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213538325000086","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The study aims to understand the Ayushman Bharat- Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) and Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY)health scheme awareness, challenges faced by the scheme beneficiaries, facilitators and out-of-pocket expenditure (OOPE) for cancer treatment at Tata Memorial Hospital, Mumbai.
Methods
We conducted an observational cross-sectional study approved by the Tata Memorial Centre Ethics Committee. We collected data by interviewing participants through a structured questionnaire.
Results
Out of 515 participants, 489 (95 %) were beneficiaries (patients/caregivers) of the schemes, 15 (2.9 %) MJPJAY staff, 6 (1.1 %) medical social workers (MSW), and 5 (1.0 %) AB PM-JAY staff. Of the 489 beneficiaries, only 162 (33.1 %) were aware of the scheme. Most patients were satisfied with the benefits of the scheme; of the 83 (17 %) who were dissatisfied, 30 (36 %) cited incomplete coverage at a 95 % Confidence Interval (CI) [0.26–0.46] and 19 (23 %) 95 % CI [0.14–0.32] cited OOPE as the reason for dissatisfaction. Participants opined a need to increase package coverage of cancer treatment and essential investigations. The beneficiaries highlighted delays in the approval process and technical issues of the scheme as potential areas of improvement.
Conclusion
Government health schemes are effective in improving treatment completion without impoverishment and have the potential to improve treatment outcomes and cancer survival. Study results indicate the need to increase awareness about these schemes in the general population, improving the health benefit packages for cancer treatment, with inclusion investigations, supportive care, nutritional care, palliative care, immunotherapy, chemotherapy drugs, targeted therapy, bone marrow transplantation, and hormonal therapy.
Policy summary
Government-funded health schemes are effective in reducing impoverishment related to healthcare costs and promoting Universal Health Coverage. However, periodic review of the breadth of coverage as well as feasibility of completing treatment using these packages is necessary to eliminate out-of-pocket expenditure and facilitate treatment completion.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
